While embryonic stem cells hold immense theoretical promise for regenerative medicine and disease cures, actual clinical applications have predominantly relied on adult stem cells (such as mesenchymal stem cells) or induced pluripotent stem cells, leaving direct cures derived specifically from embryonic stem cells less established in routine clinical practice.